SELLAS Life Sciences (SLS) Operating Leases (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Operating Leases for 6 consecutive years, with $576000.0 as the latest value for Q3 2024.
- Quarterly Operating Leases rose 223.6% to $576000.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $576000.0 through Sep 2024, up 223.6% year-over-year, with the annual reading at $460000.0 for FY2023, 19.72% down from the prior year.
- Operating Leases for Q3 2024 was $576000.0 at SELLAS Life Sciences, down from $692000.0 in the prior quarter.
- The five-year high for Operating Leases was $1.2 million in Q1 2022, with the low at $123000.0 in Q1 2020.
- Average Operating Leases over 5 years is $665421.1, with a median of $680000.0 recorded in 2022.
- The sharpest move saw Operating Leases surged 3114.29% in 2020, then plummeted 73.82% in 2023.
- Over 5 years, Operating Leases stood at $825000.0 in 2020, then fell by 26.06% to $610000.0 in 2021, then dropped by 6.07% to $573000.0 in 2022, then fell by 19.72% to $460000.0 in 2023, then rose by 25.22% to $576000.0 in 2024.
- According to Business Quant data, Operating Leases over the past three periods came in at $576000.0, $692000.0, and $313000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.